Rhumbline Advisers »

Outlook Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $76k 194k 0.39
2023-09-30 $43k 194k 0.22
2023-06-30 $338k 194k 1.74
2023-03-31 $194k 178k 1.09
2022-12-31 $157k 146k 1.08
2022-09-30 $178k 146k 1.22
2022-06-30 $138k 136k 1.02
2022-03-31 $165k 93k 1.78
2021-12-31 $65k 48k 1.36
2021-09-30 $108k 50k 2.16
2021-06-30 $115k 46k 2.50